35 completed, 32 unknown, 5 not yet recruiting, 3 recruiting. 15 Phase 4, 14 Phase 3, 10 Phase 1, 8 Not applicable, 8 Phase 2.
Follow Vaccine Reaction: new trials by email Literature Review of Vaccine Reaction trials Research Report on Vaccine Reaction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| R21/MM Dosing, Presentations, and Preservatives 10μg R21/50μg Matrix-M, 5μg R21/50μg Matrix-M with adaptor preservative free, 5μg R21/50μg Matrix-M with 2PE preservative - Plasmodium Falciparum Malaria, Malaria | Phase 4 | Not yet recruiting | University of Oxford | 375 | 2026-08-15 | 2026-08-04 |
| Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III) In-House Recombinant Hepatitis B (Bio Farma) vaccine, Registered Hepatitis B vaccine recombinant (Engerix-B) - Vaccine Reaction, Vaccine Adverse Reaction | Phase 3 | Not yet recruiting | PT Bio Farma | 540 | 2025-09-01 | 2025-06-06 |
| Safety and Immunogenicity of PCV-LITE, a Low-dose of Pneumococcal Conjugate Vaccine With LiteVax Adjuvant PCV-LITE, PCV-LITE+LVA, PCV20 - Vaccine Reaction | Phase 1 | Not yet recruiting | LiteVax BV | 80 | 2025-07-01 | 2025-05-22 |
| Optimal Timing of Hepatitis B Vaccination After Transplants hepatitis B vaccine - Transplant-Related Disorder, Hepatitis B Virus Infection | Phase 3 | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 1500 | 2025-06-01 | 2025-03-21 |
| Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants DTwP-Hepatitis B-Hib-IPV (Bio Farma) Vaccine Formula A, DTwP-Hepatitis B-Hib-IPV (Bio Farma) Vaccine Formula B, Registered DTwP-Hepatitis B-Hib Vaccine and IPV (Sinovac)® - Vaccine Adverse Reaction, Vaccine Reaction | Phase 1 / Phase 2 | Not yet recruiting | PT Bio Farma | 465 | 2025-03-01 | 2024-11-15 |
| Reduced Vaccine Response to HZ/su in SLE Vaccine Reaction, Zoster | Recruiting | Seoul National University Hospital | 80 | 2024-10-01 | 2026-06-09 | |
| Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System Gardasil, PharmaJet Stratis® Needle-Free Injection System, PharmaJet Tropis® Needle-Free Injection System - Vaccine Reaction | Phase 2 | Withdrawn | PharmaJet, Inc. | 2024-05-31 | 2024-05-24 | |
| The Non-Specific Immunological Effects of Providing Oral Polio Vaccine to Seniors in Guinea-Bissau Oral polio vaccine, Placebo - Vaccine Reaction | Phase 4 | Unknown | Bandim Health Project | 80 | 2024-01-29 | 2024-02-20 |
| Intradermal Influenza Vaccination MicronJet, Fluzone® Quadrivalent, Bacteriostatic Saline - Vaccine Reaction | Early Phase 1 | Recruiting | Yale University | 249 | 2024-01-24 | 2025-06-19 |
| Safety, Reactogenicity and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered by Jet Injection Venezuelan Equine Encephalitis DNA Vaccine, PharmaJet Stratis Needle-free Injection System, PharmaJet Tropis Needle-free Injection System - Vaccine Reaction | Phase 1 | Unknown | PharmaJet, Inc. | 46 | 2023-10-16 | 2024-05-24 |
| Immunogenicity of Concomitant Administration of COVID-19 Vaccines With Influenza Vaccines Omicron-containing COVID-19 vaccine, influenza vaccine - COVID-19, Influenza | Phase 4 | Unknown | Catholic Kwandong University | 62 | 2023-09-25 | 2024-03-26 |
| B. Infantis Supplementation to Improve Immunity in Infants Exposed to HIV B. infantis Rosell®-33, Placebo - Hiv, Vaccine Reaction | Not applicable | Recruiting | University of Cape Town | 200 | 2023-08-11 | 2024-08-22 |
| Immunogenicity and Reactogenicity of the Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta vaccine (Sanofi/GSK) - Vaccine Reaction, COVID-19 | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 248 | 2023-05-16 | 2023-06-29 |
| Immunogenicity, Reactogenicity of Shingrix in SLE Shingrix, Placebo - Zoster, Systemic Lupus Erythematosus | Phase 3 | Unknown | Seoul National University Hospital | 63 | 2023-05-08 | 2023-08-21 |
| Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children vaccinate with DTap, vaccinate with DT - Vaccine Reaction | Phase 4 | Unknown | Zhejiang Provincial Center for Disease Control and Prevention | 480 | 2023-05-01 | 2023-05-23 |
| Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children ( DTaP/DT ) vaccinate with DTaP, vaccinate with DT - Vaccine Reaction | Phase 4 | Unknown | Zhejiang Provincial Center for Disease Control and Prevention | 480 | 2023-05-01 | 2023-05-23 |
| Long COVID and Its Associations With Health Outcomes in Older Adults no interventions - Long COVID, COVID-19 Pandemic | Active not recruiting | Peking University | 11527 | 2023-04-24 | 2024-12-12 | |
| A Comparison of Safety and Immunogenicity of Rabies Pre Exposure Prophylaxis Regimen Between Gvt of India Approved and WHO Approved. Regimen 1, Regimen 2 - Vaccine Reaction | Phase 3 | Completed | Kempegowda Institute of Medical Sciences, Bangalore | 144 | 2023-04-03 | 2026-08-07 |
| Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in Infants Eupolio - Poliomyelitis, Vaccine Reaction | Phase 3 | Completed | LG Chem | 2001 | 2023-01-10 | 2025-04-06 |
| Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults S.opt.FL COVID-19 pDNA vaccine - Safety, Vaccine Reaction | Phase 1 | Unknown | Iman Almansour | 30 | 2022-11-20 | 2022-10-19 |
Showing 20 of 78. Sign in to see all of them.
COVID-19 (33) · Influenza, Human (11) · Infections (4) · Hepatitis B (3) · Malaria, Falciparum (3) · Arthritis, Rheumatoid (2) · Autoimmune Diseases (2) · Coronavirus Infections (2) · Herpes Zoster (2) · Kidney Failure, Chronic (2) · Liver Diseases (2) · Lupus Erythematosus, Systemic (2) · Orthomyxoviridae Infections (2) · Poliomyelitis (2) · Acquired Immunodeficiency Syndrome (1)
Infections (50) · Virus Diseases (50) · RNA Virus Infections (45) · Respiratory Tract Diseases (41) · Respiratory Tract Infections (41) · Lung Diseases (34) · Coronaviridae Infections (33) · Nidovirales Infections (33) · Pneumonia (33) · Pneumonia, Viral (33) · Coronavirus Infections (31) · Pathological Conditions, Signs and Symptoms (12) · Pathologic Processes (10) · Immune System Diseases (9) · Orthomyxoviridae Infections (9)
Influenza Vaccines (7) · BNT162 Vaccine (4) · COVID-19 Vaccines (3) · 2019-nCoV Vaccine mRNA-1273 (2) · Engerix-B (2) · Poliovirus Vaccine, Oral (2) · Ad26COVS1 (1) · CVnCoV COVID-19 vaccine (1) · Cholera Vaccines (1) · Grippol (1) · Health Personnel (1) · Hepatitis B Surface Antigens (1) · Hepatitis B Vaccines (1) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1) · Immunity (1)
Zhejiang Provincial Center for Disease Control and Prevention (4) · Assistance Publique - Hôpitaux de Paris (3) · PT Bio Farma (3) · Seoul National University Hospital (3) · Bandim Health Project (2) · Huashan Hospital (2) · PharmaJet, Inc. (2) · St. Petersburg Research Institute of Vaccines and Sera (2) · U.S. Army Medical Research and Development Command (2) · University of Oxford (2) · Vanderbilt University Medical Center (2) · AB Biotek (1) · ANRS, Emerging Infectious Diseases (1) · Ataturk University (1) · Beijing 302 Hospital (1)
China (14) · United States (12) · Indonesia (5) · South Korea (5) · Canada (4) · France (4) · Russia (3) · Turkey (Türkiye) (3) · Bangladesh (2) · Guinea-Bissau (2) · Italy (2) · Poland (2) · Vietnam (2) · Australia (1) · Burkina Faso (1)
Buddy Creech, MD, MPH (2) · Amina Asif, M.Phil (1) · Andrew Johnston (1) · Anne Marie R Madsen, MD, PhD (1) · Asrawati Asrawati, MD (1) · Bernie Medise, MD (1) · Bristow Michael, MD/PhD (1) · Cahya Satria, MD (1) · Carla Coffin (1) · Deekshith J Reddy, MBBS (1)
PMID 28468794, PMID 29572291, PMID 35930728, PMID 16213065, PMID 17344507, PMID 17921398, PMID 18550812, PMID 19275682, PMID 21445287, PMID 22381456, PMID 22520134, PMID 25278144, PMID 26031679, PMID 26349548, PMID 26817502, PMID 27103044, PMID 27154394, PMID 29261658, PMID 30935016, PMID 31544248, PMID 31823141, PMID 32223047, PMID 32361099, PMID 33072682, PMID 33091433, PMID 33253198, PMID 33301246, PMID 33597143, PMID 33774684, PMID 34965032, PMID 35216744, PMID 35342923, PMID 35589363, PMID 35698835, PMID 35935974, PMID 35967368, PMID 36055874, PMID 36136760, PMID 36249342, PMID 36971457, PMID 37283972, PMID 37853370, PMID 38500576, PMID 38710192, PMID 40107677, PMID 40203592, PMID 42520140, PMID 42767612, PMID 8375567
3UM1AI068614-14S1 (1), R01HD109089 (1), R44CA261326 (1), T32AR007016 (1)